Antioxidant Defense in Overt and Subclinical Hypothyroidism

Abstract

Oxidative stress as a result of disequilibrium between free radical generation and antioxidant status has been implicated in several pathologies including thyroid diseases. Studies on antioxidant status in overt (OHT) and subclinical hypothyroidism (SHT) are controversial and limited. The aim of this study was to determine the effect of OHT and SHT on antioxidant status. Thirty-six patients with OHT, 36 patients with SHT, and 39 healthy euthyroid subjects as the control group were included in the study. Plasma levels of malondialdehyde (MDA), reduced glutathione (GSH) and total antioxidant capacity (TAC) as ferric reducing ability of plasma (FRAP), and erythrocyte antioxidant enzymes superoxide dismutase (SOD), glutathione peroxidase (GPx), SOD/GPx ratios, catalase (CAT), and glutathione reductase (GR) were analyzed in all groups. MDA and GPx values were elevated, while GSH, FRAP, SOD, and SOD/GPx ratio were decreased in both patient groups compared with controls. No change in activities of CAT and GR were observed in both the patient groups. Significant differences were observed between OHT and SHT groups with high MDA, GPX and low GSH, FRAP, SOD, and SOD/GPx ratio in OHT group. Thus, hypothyroid patients have a deficient antioxidant defense in the form of decreased activity of SOD, decreased levels of FRAP and GSH along with an increase in GPx activity. The severity of the disease appears to decide the degree of deficiency and our findings also point to this, in the form of decrease in SOD, FRAP, and GSH observed being more in OHT than in SHT patients. Hormonal changes and increased lipid peroxidation, which also vary with severity of disease, appear to contribute to the antioxidant deficiency.

Key words

hypothyroidism - oxidative stress - glutathione - antioxidant status

• References

• 1 Sundaram V, Hanna AN, Koneru L, Newman HA, Falko JM. Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab 1997; 82: 3421-3424
• 2 Torun AN, Kulaksizoglu S, Kulaksizoglu M, Pamuk BO, Isbilen E, Tutuncu NB. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clin Endocrinol 2009; 70: 469-744
• 3 Guerrero A, Pamplona R, Portero-Otin M, Barja G, Lopez-Torres M. Effect of thyroid status on lipid composition and peroxidation in the mouse liver. Free Radic Biol Med 1999; 26: 73-80
• 4 Pereira B, Rosa LF, Safi DA, Bechara EJ, Curi R. Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones. J Endocrinol 1994; 140: 73-77
• 5 Yilmaz S, Ozan S, Benzer F, Canatan H. Oxidative damage and antioxidant enzyme activities in experimental hypothyroidism. Cell Biochemistry and Function 2003; 21: 325-330
• 6 Nanda N, Bobby Z, Hamide A. Association of thyroid stimulating hormone and coronary lipid risk factors with lipid peroxidation in hypothyroidism. Clin Chem Lab Med 2008; 46: 674-679
• 7 Santi A, Duarte MMMF, Moresco RN, Menezes C, Bagatini MD, Schetinger MR, Loro VL. Association between thyroid hormones, lipids and oxidative stress biomarkers in overt hypothyroidism. Clin Chem Lab Med 2010; 48: 1635-1639
• 8 Kebapcilar L, Akinci B, Bayraktar F, Comlekci A, Solak A, Demir T, Yener S, Küme T, Yesil S. Plasma thiobarbituric acid-reactive substance levels in subclinical hypothyroidism. Medical Principles and Practice 2007; 16: 432-436
• 9 Fridovich I. Superoxide radical and superoxide dismutase. Ann Rev Biochem 1995; 64: 97-112
• 10 Sies H. Strategies of antioxidant defence. Eur J Biochem 1993; 215: 213-219
• 11 deHaan JB, Cristiano F, Iannello RC, Kola I. Cu/Zn-superoxide dismutase and glutathione peroxidase during aging. Biochem Mol Biol Int 1995; 35: 1281-1297
• 12 Ozden M, Maral H, Akaydin D, Cetinalp P, Kalender B. Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients. Clin Biochem 2002; 35: 269-273
• 13 Owen JB, Butterfield DA. Measurement of oxidized/reduced glutathione ratio. Methods Mol Biol 2010; 648: 269-277
• 14 Pasupathi P, Latha R. Free Radical Activity and Antioxidant Defense Mechanisms in Patients with Hypothyroidism. Thyroid Sci 2008; 3 CLS1-6
• 15 Nanda N, Bobby Z, Hamide A, Koner BC, Sridhar MG. Association between oxidative stress and coronary lipid risk factors in hypothyroid women is independent of body mass index. Metabolism 2007; 56: 1350-1355
• 16 Carmeli E, Bachar A, Barchad S, Morad M, Merrick J. Antioxidant status in the serum of persons with intellectual disability and hypothyroidism: a pilot study. Res Dev Disabil 2008; 29: 431-438
• 17 Gerenova J, Gadjeva V. Oxidative stress and antioxidant enzyme activities in patients with hashimotos’s thyroiditis. Comp Clin Pathol 2007; 16: 259-254
• 18 Nanda N, Bobby Z, Hamide A. Oxidative stress and protein glycation in primary hypothyroidism. Male/female difference. Clin Exp Med 2008; 8: 101-108
• 19 Rahbani-Nobar M, Bahrami A, Norazarian M, Dolatkhab H. Correlation between serum levels of cholesterol and homocysteine with oxidative stress in hypothyroid patients. Int J Endocrinol Metab 2004; 2: 103-109
• 20 Erdamar H, Demirci H, Yaman H, Erbil MK, Yakar T, Sancak B, Elbeg S, Biberoğlu G, Yetkin I. The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status. Clin Chem Lab Med 2008; 46: 1004-1010
• 21 Dave BN, Paradkar NM. Total superoxide dismutase, Cu/Zn superoxide dismutase and glutathione peroxidase in untreated hyperthyroidism and hypothyroidism. JK Science 2009; 11: 6-10
• 22 Santi A, Marta MMF, Duarte MMMF, deMenezes CC, Loro VL. Association of Lipids with Oxidative Stress Biomarkers in Subclinical Hypothyroidism. Int J Endocrinol 2012; 2012: 856359 [Epub 2012 Nov 29]
• 23 Öztürk Ü, Vural P, Özderya A, Karadağ B, Doğru-Abbasoğlu S, Uysal M. Oxidative stress parameters in serum and low density lipoproteins of Hashimoto’s thyroiditis patients with subclinical and overt hypothyroidism. Int Immunopharmacol 2012; 14: 349-352
• 24 Sangeetha P, Das U, Koratkar R, Suryaprabha P. Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic Biol Med 1990; 8: 15-19
• 25 Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 1996; 239: 70-76
• 26 Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-77
• 27 Winterbourn CC, Hawkins RE, Brian M, Carrell RW. The estimation of red cell superoxide dismutase activity. J Lab Clin Med 1975; 85: 337-341
• 28 Wendel A. Glutathione peroxidase. Methods Enzymol 1981; 77: 325-333
• 29 Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126
• 30 McCormick DB, Greene HL. Tietz Textbook of Clinical Chemistry 3^rd ed. Burtis CA, Ashwood ER, (eds.) Philadelphia: W B Saunders Company; 1015-1016
• 31 Haribabu A, Seshadri Reddy V, Pallavi CH, Bitla AR, Sachan A, Pullaiah P, Suresh V, Srinivasa Rao PVLN, Suchitra MM. Evaluation of protein oxidation and its association with lipid peroxidation and thyrotropin levels in overt and subclinical hypothyroidism. Endocrine 2012; [Epub ahead of print]
• 32 Coria MJ, Pastran AI, Gimenez MS. Serum oxidative stress parameters of women with hypothyroidism. Acta Biomed 2009; 80: 135-139
• 33 Konukoglu D, Ercan M, Hatemi H. Plasma viscosity in female patients with hypothyroidism: effects of oxidative stress and cholesterol. Clinical Hemorheology and Microcirculation 2002; 27: 107-113
• 34 Dale-donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clinica Chimica Acta 2003; 329: 23-38
• 35 Zhang X, Yang F, Zhang X, Xu Y, Liao T, Song S, Wang J. Induction of hepatic enzymes and oxidative stress in Chinese rare minnow (Gobiocypris rarus) exposed to waterborne hexabromocyclododecane (HBCDD). Aquatic Toxicology 2008; 86: 4-11
• 36 Matsunami T, Sato Y, Sato T, Ariga S, Shimomura T, Yukawa M. Oxidative stress and gene expression of antioxidant enzymes in the streptozotocin-induced diabetic rats under hyperbaric oxygen exposure. Int J Clin Exp Pathol 2010; 3: 177-188
• 37 Kono Y, Fridovich I. Superoxide radical inhibits catalase. J Biol Chem 1982; 257: 5751-5754
• 38 Köhrle J. Environment and endocrinology: the case of thyroidology. Ann Endocrinol (Paris) 2008; 69: 116-122
• 39 Zitouni K, Nourooz-Zadeh J, Harry D, Kerry SM, Betteridge DJ, Cappuccio FP, Earle KA. Race-specific differences in antioxidant enzyme activity in patients with type 2 diabetes: a potential association with the risk of developing nephropathy. Diabetes Care 2005; 28: 1698-1703
• 40 Fernández V, Videla LA. Hepatic glutathione biosynthetic capacity in hyperthyroid rats. Toxicol Lett 1996; 89: 85-89
• 41 Benov L. How superoxide radical damages the cell. Protoplasma 2001; 217: 33-36
• 42 Cao G, Prior RL. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem 1998; 44: 1309-1315
• 43 Wonisch W, Falk A, Sundl I, Winklhofer-Roob BM, Lindschinger M. Oxidative stress increases continuously with BMI and age with unfavourable profiles in males. Aging Male 2012; 15: 159-165
• 44 Cornelli U, Belcaro G, Ledda A, Feragalli B. Oxidative stress following administration of levothyroxine in subjects suffering from primary hypothyroidism. Panminerva Med 2011; 53: 95-98
• 45 Moffitt TA, Garrett PJ, Hannon-Fletcher MP. Micronutrient supplementation in maintenance haemodialysis patients enhances activity of antioxidant enzymes. J Nephrol 2013; 26: 403-411